An Evidence Based Delivery Model of Care for Newly Implanted Adult CI Recipients
Sponsor: Cochlear
Terminated
FDA determination of Fox software as class III medical device, not CDSS.
A NA clinical study on Sensorineural Hearing Loss, Bilateral, this trial is terminated or withdrawn. The trial is conducted by Cochlear and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
-
Feb 2020 — Nov 2020 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 1 earlier version
-
May 2019 — Feb 2020 [monthly]
Recruiting NA
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cochlear
For direct contact, visit the study record on ClinicalTrials.gov .